rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

GlucoTrack, Inc.

GCTK · Nasdaq

Health CareMedical DevicesNot moving yet

GCTK stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 90.0% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
16 (+5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders16+5 on the quarter
New · exited8 · 2
Reported value$116K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
JANE STREET GROUP, LLCnew · filed 14 Aug 2026128,459$41K+128,459
CITADEL ADVISORS LLCnew · filed 14 Aug 202679,530$25K+79,530
Ikarian Capital, LLCunchanged · filed 14 Aug 202645,830$15K00.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202634,207$11K-12,794−27.2%
GRANITE ISLANDS PRIVATE WEALTH, LLCnew · filed 21 Jul 202615,700$5,008+15,700
BOOTHBAY FUND MANAGEMENT, LLCunchanged · filed 14 Aug 202613,525$4,31400.0%
UBS Group AGadded · filed 13 Aug 202613,343$4,257+12,641+1800.7%
CITIGROUP INCnew · filed 3 Aug 202612,872$4,106+12,872
SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 202610,546$3,364+10,546
ALERUS FINANCIAL NAunchanged · filed 14 Aug 20264,000$1,27600.0%
30 Jun 2025 – 30 Jun 2026
81216Jun 25Sep 25Dec 25Mar 26Jun 26

Everyone who traded it

Andrew K. Balo Company insiderDirector · last 3 Oct 20250 · 0
Erin Catherine Carter Company insiderDirector · last 3 Oct 20250 · 0
Luis Malave Company insiderDirector · last 3 Oct 20250 · 0
Allen Danzig Company insiderDirector · last 26 Mar 20250 · 0
John Ballantyne Company insiderDirector, 10% owner · last 26 Mar 20250 · 0
Robert Fischell Company insiderDirector · last 26 Mar 20250 · 0
Paul Goode Company insiderChief Executive Officer · last 25 Mar 20250 · 0
John A. Ballantyne Revocable Living Trust Dated 08/01/2017 Company insider10% owner · last 12 Mar 20250 · 0
Drew Sycoff Company insiderDirector, 10% owner · last 1 Jul 20241 · 0
David Podwalski Company insiderChief Commercial Officer · last 26 Jun 20170 · 0
Angela Strand Boydston Company insiderInterim Chief Strategy Officer · last 1 Jun 20170 · 0
Leslie Seff Company insiderDirector · last 1 Jun 20170 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 30 Mar 2026113%
Cash and equivalentsFY 2025 · to 31 Dec 2025$7.4M
Free cash flowFY 2025 · to 31 Dec 2025−$15.3M

Analyst forecasts

No analyst forecasts yet.